Our medicines

As a company 100% focused on HIV, ViiV Healthcare is committed to providing innovative medicines for people living with HIV globally.

Our broad portfolio consists of 12 antiretroviral medicines, offering a wide range of therapeutic options for people living with HIV.

Triumeq®

(dolutegravir/abacavir/lamivudine)

Single-tablet regimen of an integrase strand transfer inhibitor (INSTI) and two nucleoside reverse transcriptase inhibitors (NRTIs)

For further information visit our product page

Tivicay®

dolutegravir

Integrase strand transfer inhibitor (INSTI)

For further information visit our product page 

Selzentry/Celsentri®

maraviroc

CCR5 antagonist

For further information visit our product page

Epzicom/Kivexa®

abacavir/lamivudine

Fixed-dose combination regimen of two nucleoside reverse transcriptase inhibitors (NRTIs)

For further information visit our product page

Ziagen®

abacavir

Nucleoside reverse transcriptase inhibitor (NRTI)

For further information visit our product page 

Trizivir®

abacavir/lamivudine/zidovudine

Fixed-dose combination regimen of three nucleoside reverse transcriptase inhibitors (NRTIs)

For further information visit our product page

Combivir®

lamivudine/zidovudine

Fixed-dose combination regimen of two nucleoside reverse transcriptase inhibitors (NRTIs)

For further information visit our product page

Epivir/3TC®

lamivudine

Nucleoside reverse transcriptase inhibitor (NRTI)

For further information visit our product page

Retrovir/AZT®

zidovudine

Nucleoside reverse transcriptase inhibitor (NRTI)

For further information visit our product page

Lexiva/Telzir®

fosamprenavir

Protease inhibitor (PI)

For further information visit our product page

Viracept®

nelfinavir

Protease inhibitor (PI)

For further information visit our product page

Rescriptor®

delavirdine mesylate

Non-nucleoside reverse transcriptase inhibitor (NNRTI)

For further information visit our product page